AltRx Review: Low Friction, Low Entry Price — Read the Fine Print
AltRx competes on two numbers: a low advertised starting price and a short path from landing page to prescription decision. If you have already decided GLP-1 treatment is what you want and you are paying cash, that combination is exactly what you are shopping for.
The catalog covers both major active ingredients — semaglutide and tirzepatide — in compounded form, with branded options subject to eligibility and availability. Pricing is published on the site rather than revealed after signup, which we count as a genuine trust signal in this market.
The questions worth answering before you click through: what the price becomes after the promotional window, and whether a fast intake still gives a clinician enough information to screen you properly. We cover both below.
Pros and Cons
Pros
- Published starting prices — you see the number before the intake, not after
- Both semaglutide and tirzepatide tracks under one roof
- Cash-pay model with installment options; no insurance gatekeeping
- Medication and supplies ship to your door once approved
- Minimal onboarding friction for people who already know what they want
Cons
- Promotional entry pricing climbs at maintenance doses — budget on the later months
- Core affordability relies on compounded medication rather than branded products
- A fast intake puts more responsibility on you to disclose your full medical history
Highlights
- Semaglutide and tirzepatide programs with published cash prices
- Compounded tracks for affordability; branded access where eligible
- Licensed-provider review decides approval — checkout alone does not
- Home delivery of medication and injection supplies
- Subscription structure with oversight included in the monthly price
How AltRx Works
The pipeline is the standard telehealth shape, compressed: digital health intake, licensed-provider review, then an approval or decline. Approved patients receive compounded semaglutide, compounded tirzepatide, or — depending on eligibility and stock — a branded GLP-1.
Everything after approval runs remotely: shipping, refills, dose adjustments, and provider questions all happen inside the platform.
The speed is the selling point, but it cuts both ways. Answer the intake thoroughly — especially medication history, pregnancy plans, and the FDA's exclusion conditions like thyroid cancer history — because a short questionnaire only protects you if you fill it honestly.
AltRx Features
- Dual-Ingredient Catalog
Both semaglutide and tirzepatide tracks are available, so switching ingredients after a poor response does not mean switching companies. - Published Pricing
Starting monthly prices sit on the public site. You can comparison-shop before handing over any personal information — rarer in this market than it should be. - Installment-Friendly Checkout
Buy-now-pay-later options spread the monthly cost, useful for cash payers — though financing a recurring subscription deserves a clear-eyed look at the annual total. - Bundled Logistics
Approved medication ships with injection supplies included, and refills run on the subscription cycle rather than your pharmacy errands. - In-Program Oversight
Dose changes and side-effect questions route to the provider team inside the platform, which is exactly where you want them handled during titration.
Pricing
The subscription bundles three things into one monthly charge: the medication, the provider oversight, and the fulfillment. There is no separate visit fee or membership layer to track, which keeps the math honest — one number per month.
The number that matters is not the first one. Promotional entry pricing applies to starting doses; as your clinician titrates upward, the monthly cost moves with the dose. Before subscribing, ask for the price at each dose level of both tracks and sketch the twelve-month total — that figure is the real comparison point against other programs.
What you are not paying for matters too: there is no coaching apparatus or lifestyle program here. If you want habit support alongside medication, pair AltRx pricing against the coaching-inclusive programs in our chart before deciding the discount is worth it.
The Bottom Line
AltRx earns its place near the top of our chart on transparency and price: published numbers, both GLP-1 ingredients, installment options, and a checkout that does not bury the cost. For a cash payer who has already decided on GLP-1 treatment and wants the least expensive credible path in, it is a strong shortlist pick.
Choose differently if you want brand-name certainty, insurance billing, or coaching wrapped around the prescription. And whichever way you go, do the dose-level price math first — the program you can afford in month nine matters more than the one you can afford in month one.
Sources used for medical context
- NIDDK — Prescription Medications to Treat Overweight & Obesity for eligibility criteria and the FDA-approved weight-management medications.
- FDA — approval of semaglutide (Wegovy) for chronic weight management for the medication’s indication.
How we compare program terms, costs and sources.
